Journals / Turkish Neurosurgery / 2017 / Cilt: 27 - Sayı: 2

Unilateral Subthalamic Nucleus Stimulation in the Treatment of Asymmetric Parkinson's Disease with Early Motor Complications

Pages
294–300
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

COnCLuSIOn: Unilateral STN stimulation is a safe and effective procedure for selected patients with marked asymmetry Parkinson's disease motor symptoms and early motor complications.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: The aim of this study was to assess the results of unilateral subthalamic nucleus (STN) stimulation for the treatment of Parkinson's disease (PD) with marked asymmetry of parkinsonian motor symptoms and early motor complications.
📊
Key Findings & Data:MATERIAL and METhODS: The clinical series consisted of 32 consecutive PD patients, in whom unilateral STN stimulation was performed.
💡
Conclusion & Impact:COnCLuSIOn: Unilateral STN stimulation is a safe and effective procedure for selected patients with marked asymmetry Parkinson's disease motor symptoms and early motor complications.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

AIM: The aim of this study was to assess the results of unilateral subthalamic nucleus (STN) stimulation for the treatment of Parkinson's disease (PD) with marked asymmetry of parkinsonian motor symptoms and early motor complications. MATERIAL and METhODS: The clinical series consisted of 32 consecutive PD patients, in whom unilateral STN stimulation was performed. All patients were assessed according to the Unified Parkinson's Disease Rating Scale (UPDRS), and Hoehn and Yahr staging. The patients were assessed preoperatively, and at 12, and 24 months after unilateral STN stimulation. 22 patients were followed for 2 years. RESuLTS: Medication off/stimulation on total UPDRS motor scores were improved by 29% when compared to the baseline medication off motor scores. The contralateral motor scores improved by 49%, whereas the axial motor scores by 18% in medication off/stimulation on condition. The duration and severity of levodopa induced dyskinesia were reduced respectively by 73% and by 77%. The daily levodopa dose was decreased by only 10%. COnCLuSIOn: Unilateral STN stimulation is a safe and effective procedure for selected patients with marked asymmetry Parkinson's disease motor symptoms and early motor complications.

🔖

Cite This Article

SOBSTYL, M., ZABEK, M., ZACZYNSKI, A., GORECKI, W., MOSSAKOWSKI, Z., BRZUSZKIEWICZ-KUZMICKA, G. (2022). Unilateral Subthalamic Nucleus Stimulation in the Treatment of Asymmetric Parkinson's Disease with Early Motor Complications. Turkish Neurosurgery, Cilt: 27 - Sayı: 2, 294–300. https://ajindex.com/articles/616987

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Defer GL, Widner H, Marié RM, Rémy P, Levivier M: Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 14(4):572-584, 1999 2. Germano IM, Gracies JM, Weisz DJ, Tse W, Koller WC, Olanow CW: Unilateral stimulation of the subthalamic nucleus in Parkinson disease: A double-blind 12-month evaluation study. J Neurosurg 101(1):36-42, 2004 3. Goetz C, Leurgans S, Raman M: Placebo-associated improvements in motor function: Comparison of subjective and objective sections of the UPDRS in early Parkinson's disease. Mov Disord 17:283-288, 2002 4. Kim HJ, Paek SH, Kim JY, Lee JY, Lim YH, Kim DG, Jeon BS: Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease. Mov Disord 24(3):329-335, 2009 5. Kumar R, Lozano AM, Sime E, Halket E, Lang AE: Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation. Neurology 53 (3):561-566, 1999 6. Levin BE, Tomer R, Rey GJ: Cognitive impairments in Parkinson's disease. Neurol Clin 10(2):471-485, 1992 7. Levy R, Hazrati LN, Herrero MT, Vila M, Hassani OK, Mouroux M, Ruberg M, Asensi H, Agid Y, Féger J, Obeso JA, Parent A, Hirsch EC: Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states. Neuroscience 76(2):335-343, 1997 8. Linazasoro G, Van Blercom N, Lasa A: Unilateral subthalamic deep brain stimulation in advanced Parkinson's disease. Mov Disord 18(6):713-716, 2003 9. Merims D, Freedman M: Cognitive and behavioral impairment in Parkinson's disease. Int Rev Psychiatr 20(4):364-373, 2008 10. Morrison CE, Borod JC, Perrine K, Beric A, Brin MF, Rezai A, Kelly P, Sterio D, Germano I, Weisz D, Olanow CW: Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson's disease. Arch Clin Neuropsychol 19(2):165-181, 2004 11. Nakano K: Neuronal circuits and topographic organization of the basal ganglia and related regions. Brain Dev 22 Suppl 1:5- 16, 2000 12. Ostergaard K, Sunde N, Dupont E: Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations. Mov Disord 17(4): 693-700, 2002 13. Pahapill PA, Lozano AM: The pedunculopontine nucleus and Parkinson's disease. Brain 123(Pt 9): 1767-1783, 2000 14. Perez-Lloret S, Rey MV, Fabre N, Ory F, Spampinato U, BrefelCourbon C, Montastruc JL, Rascol O: Prevalence and pharmacological factors associated with imp